Skip to main content

View full-text article in PMC

. 2014 Mar 20;123(19):3016–3026. doi: 10.1182/blood-2013-10-533398

Table 1.

Summary of MDS PBMC population frequencies

	Normal (n = 20)	MDS (n = 67)	P value
CD45⁺/SSC^lo (nonmyeloid)^*	74% ± 2%	50% ± 2%	<.0001
CD45⁺/CD7⁺ lymphocytes^*	54% ± 3%	25% ± 2%	<.0001
CD56⁺/CD3⁻ NK cells^*	6% ± 1%	2% ± 0.3%	<.0001
CD56^bright/CD3⁻ NK cells^†	9% ± 2%	10% ± 2%	.84
CD56^dim/CD3⁻ NK cells^†	90% ± 2%	89% ± 2%	.85
CD56⁺/CD3⁺ NK T cells^*	1% ± 0.2%	1% ± 0.1%	.61
CD56⁻/CD3⁺ T cells^*	40% ± 3%	20% ± 2%	<.0001
CD45⁺/SSC^hi (myeloid)^*	21% ± 2%	36% ± 3%	.001
CD33⁺^*	16% ± 2%	29% ± 2%	.002
MDSCs (CD33⁺/CD11b⁺/CD14⁻/HLA-DR^lo/−)^*	0.1% ± 0.02%	6% ± 1%	<.0001

SSC, side scatter.

^*

Percent of all cells based on FSC/SSC gate excluding debris.

^†

Percent of CD7⁺/CD56⁺/CD3⁻ NK cell population.